CCN5 and familial pancreatic carcinoma: Notably, CCN5 enhances MET of pancreatic cancer cells [31] and loss of CCN5 promotes EMT and acquisition of stem cell-like phenotypes in estrogen-dependent MCF7 breast cancer cells [32].